Cisplatinum and docetaxel for ovarian cancer in pregnancy

27Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: There is limited data on chemotherapy for advanced ovarian cancer during pregnancy. Most women received cisplatin-based chemotherapy. There are no published reports on the use of docetaxel for ovarian cancer in pregnancy. Case: A 32-year-old pregnant lady underwent laparatomy at 18-week gestation for ruptured ovarian cyst. The pregnancy was the result of in vitro fertilization with intracytoplasmic sperm injection. Left salpingo-oophorectomy and omental biopsy were done. A diagnosis of stage IIIC, poorly differentiated papillary serous adenocarcinoma of the ovary was made. She was given four cycles of cisplatinum and docetaxel followed by cesarean hysterectomy, right salpingo-oophorectomy, and cytoreductive surgery. The mother is well and has completed six cycle of chemotherapy. Conclusion: This is the first report on the use of docetaxel during pregnancy for ovarian cancer. © 2009 Springer-Verlag.

Author supplied keywords

Cite

CITATION STYLE

APA

Rouzi, A. A., Sahly, N. N., Sahly, N. F., & Alahwal, M. S. (2009). Cisplatinum and docetaxel for ovarian cancer in pregnancy. Archives of Gynecology and Obstetrics, 280(5), 823–825. https://doi.org/10.1007/s00404-009-0992-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free